83 related articles for article (PubMed ID: 28371466)
1. Evaluation of the 2-(1-Hexyloxyethyl)-2-devinyl pyropheophorbide (HPPH) mediated photodynamic therapy by macroscopic singlet oxygen modeling [J. Biophotonics 9, No. 11-12, 1344-1354 (2016)].
Penjweini R; Kim MM; Liu B; Zhu TC
J Biophotonics; 2017 Mar; 10(3):473-474. PubMed ID: 28371466
[TBL] [Abstract][Full Text] [Related]
2. Evaluation of the 2-(1-Hexyloxyethyl)-2-devinyl pyropheophorbide (HPPH) mediated photodynamic therapy by macroscopic singlet oxygen modeling.
Penjweini R; Kim MM; Liu B; Zhu TC
J Biophotonics; 2016 Dec; 9(11-12):1344-1354. PubMed ID: 27653233
[TBL] [Abstract][Full Text] [Related]
3. Macroscopic singlet oxygen model incorporating photobleaching as an input parameter.
Kim MM; Finlay JC; Zhu TC
Proc SPIE Int Soc Opt Eng; 2015 Mar; 9308():93080V. PubMed ID: 25914795
[TBL] [Abstract][Full Text] [Related]
4. Explicit dosimetry for 2-(1-hexyloxyethyl)-2-devinyl pyropheophorbide-a-mediated photodynamic therapy: macroscopic singlet oxygen modeling.
Penjweini R; Liu B; Kim MM; Zhu TC
J Biomed Opt; 2015; 20(12):128003. PubMed ID: 26720883
[TBL] [Abstract][Full Text] [Related]
5. Efficacy of 2-(1-hexyloxyethyl)-2-devinyl pyropheophorbide-a in photodynamic therapy of human esophageal squamous cancer cells.
Wu D; Liu Z; Fu Y; Zhang Y; Tang N; Wang Q; Tao L
Oncol Lett; 2013 Oct; 6(4):1111-1119. PubMed ID: 24137473
[TBL] [Abstract][Full Text] [Related]
6. In-vivo outcome study of HPPH mediated PDT using singlet oxygen explicit dosimetry (SOED).
Penjweini R; Kim MM; Zhu TC
Proc SPIE Int Soc Opt Eng; 2015 Mar; 9308():. PubMed ID: 25999656
[TBL] [Abstract][Full Text] [Related]
7. Population pharmacokinetics of the photodynamic therapy agent 2-[1-hexyloxyethyl]-2-devinyl pyropheophorbide-a in cancer patients.
Bellnier DA; Greco WR; Loewen GM; Nava H; Oseroff AR; Pandey RK; Tsuchida T; Dougherty TJ
Cancer Res; 2003 Apr; 63(8):1806-13. PubMed ID: 12702566
[TBL] [Abstract][Full Text] [Related]
8. Investigating the impact of oxygen concentration and blood flow variation on photodynamic therapy.
Penjweini R; Kim MM; Finlay JC; Zhu TC
Proc SPIE Int Soc Opt Eng; 2016 Feb; 9694():. PubMed ID: 27453622
[TBL] [Abstract][Full Text] [Related]
9. Localization and treatment of transformed tissues using the photodynamic sensitizer 2-[1-hexyloxyethyl]-2-devinyl pyropheophorbide-a.
Furukawa K; Yamamoto H; Crean DH; Kato H; Mang TS
Lasers Surg Med; 1996; 18(2):157-66. PubMed ID: 8833284
[TBL] [Abstract][Full Text] [Related]
10. Gap junction enhances phototoxicity of photodynamic therapy agent 2-[1-hexyloxyethyl]-2-devinylpyropheophorbide-a (HPPH).
Liu Z; Wang Q; Fan L; Wu DP; Zhang Y; Liu L; Tao L
Lasers Surg Med; 2015 Jan; 47(1):68-76. PubMed ID: 25483871
[TBL] [Abstract][Full Text] [Related]
11. A Phase I Study of Light Dose for Photodynamic Therapy Using 2-[1-Hexyloxyethyl]-2 Devinyl Pyropheophorbide-a for the Treatment of Non-Small Cell Carcinoma In Situ or Non-Small Cell Microinvasive Bronchogenic Carcinoma: A Dose Ranging Study.
Dhillon SS; Demmy TL; Yendamuri S; Loewen G; Nwogu C; Cooper M; Henderson BW
J Thorac Oncol; 2016 Feb; 11(2):234-41. PubMed ID: 26718878
[TBL] [Abstract][Full Text] [Related]
12. In vivo spectroscopic evaluation of human tissue optical properties and hemodynamics during HPPH-mediated photodynamic therapy of pleural malignancies.
Morales RDH; Hong Ong Y; Finlay J; Dimofte A; Simone CB; Friedberg JS; Busch TM; Cengel KA; Zhu TC
J Biomed Opt; 2022 Oct; 27(10):. PubMed ID: 36316298
[TBL] [Abstract][Full Text] [Related]
13. Determination of the low concentration correction in the macroscopic singlet oxygen model for PDT.
Kim MM; Penjweini R; Finlay JC; Zhu TC
Proc SPIE Int Soc Opt Eng; 2015 Mar; 9694():96940D. PubMed ID: 27053824
[TBL] [Abstract][Full Text] [Related]
14. Comparison of PDT parameters for RIF and H460 tumor models during HPPH-mediated PDT.
Liu B; Kim MM; Gallagher-Colombo SM; Busch TM; Zhu TC
Proc SPIE Int Soc Opt Eng; 2014 Mar; 8931():. PubMed ID: 25999649
[TBL] [Abstract][Full Text] [Related]
15. Tumor vascular response to photodynamic therapy and the antivascular agent 5,6-dimethylxanthenone-4-acetic acid: implications for combination therapy.
Seshadri M; Spernyak JA; Mazurchuk R; Camacho SH; Oseroff AR; Cheney RT; Bellnier DA
Clin Cancer Res; 2005 Jun; 11(11):4241-50. PubMed ID: 15930363
[TBL] [Abstract][Full Text] [Related]
16. Comparison of singlet oxygen threshold dose for PDT.
Zhu TC; Liu B; Kim MM; McMillan D; Liang X; Finlay JC; Busch TM
Proc SPIE Int Soc Opt Eng; 2014 Feb; 8931():. PubMed ID: 25999651
[TBL] [Abstract][Full Text] [Related]
17. Explicit macroscopic singlet oxygen modeling for benzoporphyrin derivative monoacid ring A (BPD)-mediated photodynamic therapy.
Kim MM; Penjweini R; Liang X; Zhu TC
J Photochem Photobiol B; 2016 Nov; 164():314-322. PubMed ID: 27721165
[TBL] [Abstract][Full Text] [Related]
18. Establishment and comparison of three novel methods for the determination of the photodynamic therapy agent 2-[1-hexyloxyethyl]-2-devinyl pyropheophorbide-a (HPPH) in human serum.
Chen L; Xiao Q; Zhang X; Yang J
J Pharm Biomed Anal; 2016 Mar; 121():13-21. PubMed ID: 26773535
[TBL] [Abstract][Full Text] [Related]
19. Simple photodynamic therapy dose models fail to predict the survival of MLL cells after HPPH-PDT in vitro.
Weston MA; Patterson MS
Photochem Photobiol; 2009; 85(3):750-9. PubMed ID: 19140895
[TBL] [Abstract][Full Text] [Related]
20. A Comparison of Dose Metrics to Predict Local Tumor Control for Photofrin-mediated Photodynamic Therapy.
Qiu H; Kim MM; Penjweini R; Finlay JC; Busch TM; Wang T; Guo W; Cengel KA; Simone CB; Glatstein E; Zhu TC
Photochem Photobiol; 2017 Jul; 93(4):1115-1122. PubMed ID: 28083883
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
